Relax Pharmaceuticals Private Limited

Relax Pharmaceuticals Private Limited - pharma in Saharanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24231DL1997PTC461314 Incorporated 31 July 1997 ROC Kanpur HQ Saharanpur, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹215.76 Cr
▲ 29% YoY
Net profit · FY 2024
₹16.13 Cr
Net margin 7.5%
EBITDA · FY 2024
₹23.97 Cr
EBITDA margin 11.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹51.38 Cr
Satisfied ₹23.1 Cr
Company age
29 yrs
Est. 1997
Directors on board
6
As per MCA filings

About Relax Pharmaceuticals Private Limited

Data last updated:

Relax Pharmaceuticals Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India, a subsidiary of Mankind Pharma Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 1997 and has been in existence for over 29 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231DL1997PTC461314. Its GSTIN is 02AAACR9253R2ZW (Himachal Pradesh). The company holds 5 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹30 Lakh. It is led by directors including Vikash Sharma (Whole-Time Director) and Abhay Kumar Srivastava.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 Behind Employment Exchange Shastri Nagar, Saharanpur, Uttar Pradesh, India – 247001.

As per the financials filed for FY 2024, the company reported a revenue of ₹215.76 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹16.13 Cr (net margin 7.5%) and EBITDA of ₹23.97 Cr (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 9% over five years.

The company is associated with 1 brand: Relax Pharmaceuticals. As per MCA filings, the company has open charges of ₹51.38 Cr and satisfied charges of ₹23.1 Cr on record. Court records list 9 cases involving the company, including 7 filed by the company and 2 filed against it; 3 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in October 2017. Its 4 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Naprod Life Sciences Private Limited with revenue of ₹219.65 Cr. The company has 9 MSME Form 1 returns on record between 2022 and 2023, listing 2,026 overdue payments to 47 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website relaxpharmaceuticals.in.

Company details

CIN U24231DL1997PTC461314
Registration Number 022390
Incorporation Date 31 July 1997
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Mankind Pharma Limited
Compliance Status Active Compliant

CIN history

Relax Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231UP1997PTC022390. The current CIN is U24231DL1997PTC461314, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231DL1997PTC461314Current
U24231UP1997PTC022390Previous

Contact details

Relax Pharmaceuticals Private Limited's registered office is in Saharanpur, Uttar Pradesh.

  • Registered Address
    2 Behind Employment Exchange Shastri Nagar, Saharanpur, Uttar Pradesh, India – 247001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Relax Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Relax Pharmaceuticals operates one associated brand: Relax Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Offers formulation development and supply chain services for the pharmaceutical industry.relaxpharmaceuticals.in

Business activity

The main business activities of Relax Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and architecture, engineering activities, technical testing and analysis activities. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
MProfessional, Scientific and TechnicalM4Architecture, engineering activities, technical testing and analysis activities

To see the full business activity and turnover split of Relax Pharmaceuticals Private Limited, buy the company report.

Financials of Relax Pharmaceuticals Private Limited

FY 2025 filings available

Relax Pharmaceuticals Private Limited reported revenue of ₹215.76 Cr (up 29% YoY) for FY 2024.

Revenue · FY 2024
₹215.76 Cr ▲ 29%
Net profit · FY 2024
₹16.13 Cr margin 7.5%
EBITDA · FY 2024
₹23.97 Cr margin 11.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 22%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 37%
5 years · compounded
▲ 13%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 29% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹23.97 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹16.13 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin11.1%
Net Profit Margin7.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Relax Pharmaceuticals Private Limited, buy the company report.

Board of directors of Relax Pharmaceuticals Private Limited

Relax Pharmaceuticals has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Abhay Kumar SrivastavaDirector01 Mar 20215 Years 7 MonthsCurrent
Akhlas AhmedDirector01 Mar 20215 Years 7 MonthsCurrent
Veer Singh PalDirector31 Jul 199729 Years 2 MonthsCurrent
Vikash SharmaWhole-Time Director08 Aug 20242 Years 2 MonthsCurrent
Bhupendra KaushikDirector26 Mar 20215 Years 7 MonthsCurrent
Anju Kumari JhaDirector26 Mar 20215 Years 7 MonthsCurrent

Peer comparison

Relax Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Naprod Life Sciences Private Limited₹219.65 Cr (FY 2025)1.0%Mumbai, Maharashtra, India
Makson Healthcare Private Limited₹217.91 Cr (FY 2024)-2.0%Mandideep, Madhya Pradesh, India
Relax Pharmaceuticals Private Limitedthis company₹215.76 Cr (FY 2024)₹16.13 Cr7.5%29.0%Saharanpur, Uttar Pradesh, India
Rivpra Formulation Private Limited₹215.35 Cr (FY 2025)-7.0%New Delhi, Delhi, India
Speciality Organics Pvt Ltd₹214.1 Cr (FY 2025)34.0%Mandideep, Madhya Pradesh, India

To see the full peer comparison of Relax Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹51.38 Cr
Satisfied charges
₹23.1 Cr
Breakdown by lending institutions
Others₹51.38 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 Oct 2024101012840Others₹50 CrOpen
17 Apr 2021100441910Others₹1.38 CrOpen
30 Jul 201210371499Hdfc Bank Limited₹10 CrSatisfied
30 Jul 201210371555Hdfc Bank Limited₹10 CrSatisfied
15 Nov 201010254777Member Secretory Single Window Clearance Agency₹30 LakhSatisfied

To see the full charge records of Relax Pharmaceuticals Private Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Relax Pharmaceuticals Private Limited has 3 deals on record (3 secondary share transfers); the latest was in October 2017.

Total deals
3
Secondary share transfers
3

Deals on record (3 of 3)

WhenDealAmountParties
Oct 2017Secondary share transferUndisclosedBuyer: Mankind Pharma Limited
Seller: 3 individuals
Jan 2016Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Relax Pharmaceuticals Private Limited has 9 MSME Form 1 returns on record between 2022 and 2023, listing 2,026 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 47)

SupplierAmount dueDue sinceReported on
A to Z Packers
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Relax Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Relax Pharmaceuticals has 5 GST registrations: 3 active and 2 cancelled or inactive.

Total GSTINs
5
Active
3
Cancelled / inactive
2
GSTINStateStatusRegistered on
02AAACR9253R2ZWHimachal PradeshActive01 Jul 2017
19AAACR9253R1ZIWest BengalActive31 Oct 2018
23AAACR9253R1ZTMadhya PradeshActive02 Nov 2018

To see the full GST registrations and return filing status of Relax Pharmaceuticals Private Limited, buy the company report.

Recent activity

Relax Pharmaceuticals Private Limited has 16 board changes on record since 1997: 6 appointments and 10 cessations. The latest: Vikash Sharma was appointed as Whole-Time Director on 08 Aug 2024.

AGM
Relax Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Relax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101012840 was registered on 16 Oct 2024.
Appointed
Vikash Sharma was appointed as Whole-Time Director.
Ceased
Vikash Sharma ceased to be Additional Director.
Ceased
Abhay Kumar Srivastava ceased to be Additional Director.
Ceased
Akhlas Ahmed ceased to be Additional Director.
Ceased
Anju Kumari Jha ceased to be Additional Director.
Ceased
Bhupendra Kaushik ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 1.38 Cr with Charge ID 100441910 was registered on 17 Apr 2021.
Appointed
Anju Kumari Jha was appointed as Director.
Appointed
Bhupendra Kaushik was appointed as Director.

22 earlier events are in the company report.

Frequently asked questions

Relax Pharmaceuticals is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 July 1997 (29+ years old) and is registered under CIN U24231DL1997PTC461314.

Relax Pharmaceuticals has 6 current directors:

The latest financial statements of Relax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Relax Pharmaceuticals is 02AAACR9253R2ZW, registered in Himachal Pradesh. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 19AAACR9253R1ZI (West Bengal), 23AAACR9253R1ZT (Madhya Pradesh).

The CIN (Corporate Identification Number) of Relax Pharmaceuticals is U24231DL1997PTC461314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Relax Pharmaceuticals has 9 court cases on record: 7 filed by the company and 2 filed against it. 3 are pending. Most are in the high courts.

Relax Pharmaceuticals was incorporated on 31 July 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kanpur.

Relax Pharmaceuticals has 3 deals on record (3 secondary share transfers); the latest was in October 2017.

The peers of Relax Pharmaceuticals by revenue are Naprod Life Sciences Private Limited, Makson Healthcare Private Limited, Rivpra Formulation Private Limited, Speciality Organics Pvt Ltd, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Vikash Sharma was appointed as Whole-Time Director on 08 Aug 2024. Vikash Sharma ceased to be Additional Director on 08 Aug 2024. Abhay Kumar Srivastava ceased to be Additional Director on 27 Nov 2021. Relax Pharmaceuticals has 16 board changes on record in total.

Relax Pharmaceuticals has 9 MSME Form 1 returns on record between 2022 and 2023, listing 2,026 overdue payments to 47 micro and small suppliers. The latest return was filed on 17 Jan 2024.

Relax Pharmaceuticals can be reached through the website relaxpharmaceuticals.in. Its registered office is in Saharanpur, Uttar Pradesh, India.